Research Article

Early Complication in Sickle Cell Anemia Children due to A(TA)nTAA Polymorphism at the Promoter of UGT1A1 Gene

Table 1

Hematological, demographic, and clinical data of studied population.

Normal valuesSCA patients with 
cholelithiasis
SCA patients without 
cholelithiasis
Patients with 
cholelithiasis
MF

Number52 SS50 SS76 AA
Age (mean) 0.4250.020
Sex ratio (M/F)24/2820/3033/430.4230.323
Hb (g/dL)13–1812–16 0.5210.035
RBC (1012/L)4.5–6.24–5.4 0.2700.120
MCV (fL)80–10080–100 0.5600.049
MCH (pg)27–3227–32 0.1000.130
RDW (%)11–1411–14 0.5790.029
HbA (%)97-9897-9800 10.012
HbS (%)00 010.012
HbF (%)00 010.012
HbA2 (%)2-32-3 10.012
Total bilirubin level ( mol/L)<17<1780.2553.530.30.0010.020
Unconjugated bilirubin level ( mol/L)<14<1470.1238.225.80.0010.035
Conjugated bilirubin level ( mol/L)<14<1410.1315.34.50.0010.120

Usual value of total bilirubin level is <17  mol/L.
SS: homozygous of -globin gene mutation.
AA: normal adult hemoglobin.
The demographic and hematologic values are indicated as mean ± standard deviation.
The bilirubin values are indicated as medians.
Hb: hemoglobin, RBC: red blood cell, MCV: mean corpuscular volume, MCH: mean corpuscular hemoglobin, and RDW: red blood distribution width.
Statistics for the comparison of demographic and hematological variables between the two groups were performed using the -test and chi-square test as appropriate (SPSS 18.0).
Statistics for the comparison of bilirubin level between the two groups were performed using the nonparametric Mann-Whitney test (SPSS 18.0).
: index of significance, each is considered as significant. : comparison between SCA patients according to the presence or the absence of cholelithiasis. : comparison between SCA patients without cholelithiasis and patients with cholelithiasis.